Faculty Bibliography

Dr. Francis S. Collins, the head of the government's project to map all human genes, said Tuesday that he is retracting five research papers on leukemia in leading scientific journals because a junior colleague fabricated data. The flawed papers involved laboratory research on the role of a defective gene in producing acute leukemia. The research did not involve patients or treatment of the disease. Upon learning of the problem in mid-August, Collins said in an interview, he 'thought it was an isolated instance whereby a trainee in my laboratory manipulated the data.'

Dr. Francis S. Collins, the head of the government's project to map all human genes, said yesterday that he was retracting five research papers on leukemia in leading scientific journals because a junior colleague fabricated data. On learning of the problem in mid-August, Collins said in an interview, he 'thought it was an isolated instance whereby a trainee in my laboratory manipulated the data.' Collins and officials at the institutes declined to name the student for legal reasons. But the student was identified as Amitov Hajra through an examination of the papers that Collins said he is retracting. One paper lists only two authors, Hajra and Collins

According to preliminary findings from a small study, the skin tumors of Kaposi's sarcoma, the most common form of cancer among people with AIDS, often yielded to injections of human chorionic gonadotropin, or hCG, a hormone produced in pregnancy. The study of 36 men is being reported on Oct 24, 1996 in the New England Journal of Medicine

A new study being published on Oct 23, 1996 in The Journal of the American Medical Association reports that medical emergencies caused by very high blood pressure are often treated with a drug that is neither safe nor effective for the condition. The report found that patients taking the drug, the short-acting form of nifedipine, had suffered strokes, heart attacks and other serious, sometimes fatal, complications after taking the drug

In his first interview about his health, President Clinton said that it was ``very good,'' that he had never had a serious illness and that he had controlled his three most pesky problems: hoarseness, allergies and weight. Clinton, 50, pledged in the interview Saturday to tell the public if he developed any serious illness while in the White House. From the moment he took office, he has had ready a detailed written plan on how to activate the 25th Amendment if he is ever disabled and Vice President Al Gore needs to assume the duties of president

[Clinton] said he had overcome the problem of hoarseness that hampered his 1992 campaign by drinking copious amounts of water, not eating late at night, raising the head of his bed and taking a drug, Prilosec, or omeprazole, and occasional antacids. Clinton fights allergies with desensitization shots that he takes every week, a non-sedating antihistamine and decongestant drug, Claritin-D, and an anti-inflammatory steroid nasal spray, called Nasalide

In an Oct 13, 1996 interview, President Clinton discussed his health for the first time, saying that he was in 'very good' health and that he would tell the public if he developed any serious illness while in the White House